I agree that this site is using cookies. You can find further informations here.
X
Elizabeth Oosterhuis, B.
162  results:
Search for persons X
?
1

Attitudes and practices of pediatric oncology providers reg..:

Goodwin, Tress ; Elizabeth Oosterhuis, B. ; Kiernan, Michaela..
Pediatric Blood & Cancer.  48 (2006)  1 - p. 80-85 , 2006
Link: https://doi.org/10.1002/..
 
?
2

Concerns about infertility risks among pediatric oncology p..:

Oosterhuis, B. Elizabeth ; Goodwin, Tress ; Kiernan, Michaela..
Pediatric Blood & Cancer.  50 (2007)  1 - p. 85-89 , 2007
Link: https://doi.org/10.1002/..
 
?
3

COMENIUS' STELLUNG ZU DEN NEO-REFORMATOREN:

OOSTERHUIS, R. A. B.
Nederlands archief voor kerkgeschiedenis / Dutch Review of Church History.  23 (1930)  - p. 43-59 , 1930
Link: https://www.jstor.org/st..
 
?
4

Comenius' Stellung Zu Den Neo-Reformatoren:

Oosterhuis, R.A.B.
Nederlands Archief voor Kerkgeschiedenis / Dutch Review of Church History.  23 (1930)  1 - p. 43-59 , 1930
Link: https://doi.org/10.1163/..
 
?
5

Berry anthocyanins and anthocyanidins exhibit distinct affi..:

Dreiseitel, A ; Oosterhuis, B ; Vukman, KV...
British Journal of Pharmacology.  158 (2009)  8 - p. 1942-1950 , 2009
Link: https://doi.org/10.1111/..
 
?
6

Determination of the Bioavailability of [14C]‐Hexaminolevul..:

Klem, B. ; Lappin, G. ; Nicholson, S....
The Journal of Clinical Pharmacology.  46 (2006)  4 - p. 456-460 , 2006
Link: https://doi.org/10.1177/..
 
?
7

Use of microdosing to predict pharmacokinetics at the thera..:

LAPPIN, G ; KUHNZ, W ; JOCHEMSEN, R...
Clinical Pharmacology & Therapeutics.  80 (2006)  3 - p. 203-215 , 2006
Link: https://doi.org/10.1016/..
 
?
8

Pharmacokinetic profile of a modified release formulation o..:

Barré, J. ; Ledudal, P. ; Oosterhuis, B....
Biopharmaceutics & Drug Disposition.  24 (2003)  4 - p. 159-164 , 2003
Link: https://doi.org/10.1002/..
 
?
9

Dose‐finding and efficacy study for i.m. artemotil (beta‐ar..:

Looareesuwan, S. ; Oosterhuis, B. ; Schilizzi, B. M....
British Journal of Clinical Pharmacology.  53 (2002)  5 - p. 492-500 , 2002
Link: https://doi.org/10.1046/..
 
?
10

The prevalence of CYP2D6 and CYP2C19 genotypes in a populat..:

Tamminga, W. ; Wemer, J. ; Oosterhuis, B....
European Journal of Clinical Pharmacology.  57 (2001)  10 - p. 717-722 , 2001
Link: https://doi.org/10.1007/..
 
?
11

CYP2D6 and CYP2C19 activity in a large population of Dutch ..:

Tamminga, W. J. ; Wemer, J. ; Oosterhuis, B....
European Journal of Clinical Pharmacology.  55 (1999)  3 - p. 177-184 , 1999
Link: https://doi.org/10.1007/..
 
?
12

A study comparing biopharmaceutic characteristics of four o..:

Hendriks, MGC ; Dogterom, P ; Ebels, JT...
Fundamental & Clinical Pharmacology.  12 (1998)  5 - p. 559-565 , 1998
Link: https://doi.org/10.1111/..
 
?
13

Rational experimental design for bioanalytical methods vali..:

Wieling, J. ; Hendriks, G. ; Tamminga, W.J....
Journal of Chromatography A.  730 (1996)  1-2 - p. 381-394 , 1996
Link: https://doi.org/10.1016/..
 
?
14

The effect of oxprenolol dosage time on its pharmacokinetic..:

Koopmans, R. ; Oosterhuis, B. ; Karemaker, J. M...
European Journal of Clinical Pharmacology.  44 (1993)  2 - p. 171-176 , 1993
Link: https://doi.org/10.1007/..
 
?
15

Clinical pharmacokinetics and tolerability of alpidem in he..:

Jonkman, J. H. G. ; Bianchetti, G. ; Grasmeijer, G....
European Journal of Clinical Pharmacology.  41 (1991)  4 - p. 369-374 , 1991
Link: https://doi.org/10.1007/..
 
1-15